Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Gene-Environment-Time Interactions in Neurodegenerative Diseases: Hypotheses and Research Approaches.

Bradley WG, Andrew AS, Traynor BJ, Chiò A, Butt TH, Stommel EW.

Ann Neurosci. 2018 Dec;25(4):261-267. doi: 10.1159/000495321. Epub 2018 Dec 4.

2.

Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases.

Facciponte DN, Bough MW, Seidler D, Carroll JL, Ashare A, Andrew AS, Tsongalis GJ, Vaickus LJ, Henegan PL, Butt TH, Stommel EW.

Sci Total Environ. 2018 Dec 15;645:1003-1013. doi: 10.1016/j.scitotenv.2018.07.226. Epub 2018 Jul 20.

3.

Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk.

Andrew AS, Chen CY, Caller TA, Tandan R, Henegan PL, Jackson BP, Hall BP, Bradley WG, Stommel EW.

Muscle Nerve. 2018 Jan 4. doi: 10.1002/mus.26055. [Epub ahead of print]

4.

Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS).

Kuczmarski T, Stommel EW, Riley K, Tandan R, Chaudhry V, Clawson L, Caller TA, Henegan PL, Facciponte DN, Bradley WG, Andrew AS.

J Neurol. 2017 Aug;264(8):1763-1767. doi: 10.1007/s00415-017-8564-2. Epub 2017 Jul 15.

PMID:
28711998
5.

Environmental and Occupational Exposures and Amyotrophic Lateral Sclerosis in New England.

Andrew AS, Caller TA, Tandan R, Duell EJ, Henegan PL, Field NC, Bradley WG, Stommel EW.

Neurodegener Dis. 2017;17(2-3):110-116. doi: 10.1159/000453359. Epub 2017 Jan 26.

6.

Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland.

Bradley WG, Stommel EW, Shi X, Torbick NM, Caller TA, Sabel CE, Rooney JP, Staines A, Hardiman O.

Neurology. 2015 Nov 17;85(20):1822-3. doi: 10.1212/01.wnl.0000473800.89178.a9. No abstract available.

PMID:
26574539
7.

The Epidemiology of Amyotrophic Lateral Sclerosis in New Hampshire, USA, 2004-2007.

Caller TA, Andrews A, Field NC, Henegan PL, Stommel EW.

Neurodegener Dis. 2015;15(4):202-6. doi: 10.1159/000374117. Epub 2015 Apr 16.

PMID:
25896575
8.

Spinal magnetic resonance imaging in chronic poliomyelitis.

Ziller MG, Stommel EW.

J Clin Neuromuscul Dis. 2014 Sep;16(1):24. doi: 10.1097/CND.0000000000000041. No abstract available.

PMID:
25137513
9.

A case of acute combined central and peripheral demyelination.

Thomas AA, Stommel EW.

J Clin Neuromuscul Dis. 2014 Mar;15(3):112-6. doi: 10.1097/CND.0000000000000025.

PMID:
24534834
10.

Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009.

Caller TA, Chipman JW, Field NC, Stommel EW.

Muscle Nerve. 2013 Aug;48(2):235-41. doi: 10.1002/mus.23761.

PMID:
23881670
11.

Linking β-methylamino-L-alanine exposure to sporadic amyotrophic lateral sclerosis in Annapolis, MD.

Field NC, Metcalf JS, Caller TA, Banack SA, Cox PA, Stommel EW.

Toxicon. 2013 Aug;70:179-83. doi: 10.1016/j.toxicon.2013.04.010. Epub 2013 May 6.

PMID:
23660330
12.

Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases?

Bradley WG, Borenstein AR, Nelson LM, Codd GA, Rosen BH, Stommel EW, Cox PA.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):325-33. doi: 10.3109/21678421.2012.750364. Epub 2013 Jan 4. Review.

PMID:
23286757
13.

Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.

Stommel EW, Field NC, Caller TA.

Med Hypotheses. 2013 Feb;80(2):142-5. doi: 10.1016/j.mehy.2012.11.012. Epub 2012 Dec 14.

PMID:
23246360
14.

Acute bilateral painless radiculitis with abnormal Borrelia burgdorferi immunoblot.

Almodovar JL, Hehir MK, Nicholson KA, Stommel EW.

J Clin Neuromuscul Dis. 2012 Dec;14(2):75-7. doi: 10.1097/CND.0b013e318279d634.

PMID:
23172387
15.

Anti-inflammatory efficacy of dexamethasone and Nrf2 activators in the CNS using brain slices as a model of acute injury.

Graber DJ, Hickey WF, Stommel EW, Harris BT.

J Neuroimmune Pharmacol. 2012 Mar;7(1):266-78. doi: 10.1007/s11481-011-9338-8. Epub 2012 Jan 17.

PMID:
22249489
16.

Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA.

Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW.

Amyotroph Lateral Scler. 2012 Jan;13(1):25-32. doi: 10.3109/17482968.2011.621436. Review.

PMID:
22214351
17.

The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.

Banack SA, Caller TA, Stommel EW.

Toxins (Basel). 2010 Dec;2(12):2837-50. doi: 10.3390/toxins2122837. Epub 2010 Dec 20. Review.

18.

An explanation for the changes in collagen in sporadic amyotrophic lateral sclerosis.

Field NC, Caller TA, Stommel EW.

Med Hypotheses. 2011 Oct;77(4):565-7. doi: 10.1016/j.mehy.2011.06.032. Epub 2011 Jul 13.

PMID:
21745715
19.

A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms.

Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, Ball A, Harris BT, Stommel EW.

Amyotroph Lateral Scler. 2009;10 Suppl 2:101-8. doi: 10.3109/17482960903278485.

PMID:
19929741
20.

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial.

Stommel EW, Cohen JA, Fadul CE, Cogbill CH, Graber DJ, Kingman L, Mackenzie T, Channon Smith JY, Harris BT.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):393-404. doi: 10.3109/17482960802709416.

Supplemental Content

Loading ...
Support Center